Mr. Hood is a Managing Director and the Founder of William Hood & Company, a differentiated industry-focused investment banking practice covering the Consumer, Food and Retail sectors. William Hood & Company is a division of AXIA Capital Markets LLC, a U.S. registered broker-dealer and member of FINRA.
Prior to founding William Hood & Company, Mr. Hood was a Managing Director at Houlihan Lokey where he led the firm’s Consumer Health and Wellness practice. Over a period of almost eight years, Mr. Hood built the leading nutritionals practice on Wall Street, having led or been involved in many of the largest and best-known transactions in the industry. Mr. Hood’s transaction experience includes the recently announced sale of Atrium Innovations to Nestle for $2.3 billion, the sale of the Nature’s Bounty Company from The Carlyle Group to KKR, the sale of UK-based Holland & Barrett to Letter1 Retail for $2.4 billion, the sale of Iovate to Xiwang Foods for $730 million, the sale of Jamieson to CCMP, the sale of Schiff Nutrition to Reckitt Benckiser for $1.4 billion, the sale of the Avid Health to Church & Dwight for $650 million and the sale of Emergen-C to Pfizer among many others.
Widely regarded as an expert within the space, Mr. Hood is frequently invited to speak about M&A at key Health and Wellness industry events including Expo West, the Nutrition Business Journal Summit, Supply Side West and ACG. Mr. Hood is also a key contributor to both industry and financial publications and has been interviewed and quoted about matters of M&A in the Wall Street Journal, Bloomberg News, Nutrition Business Journal, Whole Foods Magazine and the Daily Deal, among others.
Mr. Hood has a broad global network and travels frequently to Europe, Asia and Latin America. He grew up in the U.K. and Hong Kong and holds a B.S. from Georgetown University.
Mr. Hood holds the following FINRA Registrations: Series 7, 24, 63 and 79.